Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure
Abstract Background Recent studies indicated that sodium glucose cotransporter (SGLT)2 inhibition increases levels of ketone bodies in the blood in patients with type 1 and 2 diabetes. Other studies suggested that in patients with chronic heart failure (CHF), increased myocardial oxygen demand can b...
Saved in:
Main Authors: | R. Pietschner, J. Kolwelter, A. Bosch, K. Striepe, S. Jung, D. Kannenkeril, C. Ott, M. Schiffer, S. Achenbach, R. E. Schmieder |
---|---|
Format: | article |
Language: | EN |
Published: |
BMC
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b7b30358f28b414ca7ef3d20f55fd8c2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The New Heart Failure Association Definition of Advanced Heart Failure
by: Marco Metra, et al.
Published: (2019) -
Hidden in Heart Failure
by: Douglas Ewan Cannie, et al.
Published: (2019) -
Hyperkalaemia in Heart Failure
by: Umar Ismail, et al.
Published: (2021) -
Evaluation of the Effect of Heart Failure Reversal Therapy on Exercise Capacity in Patients with Chronic Heart Failure and the Association with Co-morbidities
by: R Sane
Published: (2020) -
Evaluation of the Effect of Heart Failure Reversal Therapy on Anthropometric Obesity Parameters in Patients with Chronic Heart Failure: A Retrospective Analysis
by: R Sane
Published: (2020)